• Policy
• COVID-19 vaccine budget KRW 857.1 Bln received
• by Kim, Jung-Ju Jan 14, 2021 06:15am

• Policy
• There is progress in introducing additional COVID-19 vaccine
• by Lee, Jeong-Hwan Jan 14, 2021 06:15am

• Policy
• All citizens will be vaccinated free of charge
• by Lee, Jeong-Hwan Jan 14, 2021 06:15am

• Policy
• MFDS OK's removing “redundant” narcotics return approval
• by Lee, Jeong-Hwan Jan 13, 2021 06:12am

• Company
• JW Pharma is speeding up the development of Dumirox·Actemra
• by Jan 13, 2021 06:12am

• Company
• Sanofi financially supports adolescent Dupixent users
• by Jan 13, 2021 06:11am

• Company
• Ferring & Chong Kun Dang signed a contract for Nocdurna
• by Jan 13, 2021 06:11am

• Company
• Celltrion's CT-T43 was approved for Phase III clinical trial
• by Kim, Jin-Gu Jan 13, 2021 06:10am

• Company
• What domestic pharmaceuticals JP Morgan paid attention to?
• by Moon, sung-ho Jan 12, 2021 06:22am

• Policy
• 9 Atozet generic companies to join CKD via consignment
• by Lee, Tak-Sun Jan 12, 2021 06:22am